Recombinant Human BMPR-IA/ALK-3 Protein

Product Discontinued

Recombinant Human BMPR-IA/ALK-3 Protein Summary

• Description: A recombinant protein corresponding to Human BMPR-IA/ALK-3
• Preparation Method: >90% SDS-PAGE
• Details of Functionality: Biological Activity: Measured by its ability to inhibit recombinant human BMP-2 induced alkaline phosphatase production by C2C12 myogenic cells. The ED50 for this effect is typically 1-3 ug/ml in the presence of 500 ng/ml of recombinant human BMP-2.
• Protein/Peptide Type: Recombinant Protein
• Gene: BMPR1A
• Purity: >90% SDS-PAGE

Applications/Dilutions

• Theoretical MW: 23 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: From sterile PBS.
• Concentration: Lyoph
• Purity: >90% SDS-PAGE
• Reconstitution Instructions: Centrifuge prior to opening. Reconstitute with sterilized PBS to a final concentration greater than or equal to 0.1 mg/ml.

Notes

After reconstituted, dilute further with other aqueous solutions.

Alternate Names for Recombinant Human BMPR-IA/ALK-3 Protein

• ACVRLK310q23del
• ALK-3
• ALK3EC 2.7.11.30
• BMP type-1A receptor
• BMPR1A
• BMPR-1A
• BMPRIA
• BMPR-IA
• bone morphogenetic protein receptor type-1A
• bone morphogenetic protein receptor, type IA
• CD292 antigen
• CD292
• EC 2.7.11
• Serine/threonine-protein kinase receptor R5
• SKR5
• type II-like kinase 3

Background

The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the Activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kDa and type II receptors of about 70-80 kDa. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. BMPR1A Human Recombinant extracellular domain produced in baculovirus is a monomeric, glycosylated, polypeptide chain fused with 6xHis tag at C-terminus and having a molecular mass of 23 kDa. The BMR1A is purified by proprietary chromatographic techniques.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: BMPR1A